Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. IBM
6. MU
7. FDX
8. BLZE
9. NKE
10. PRIM

Go back to Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update
(NASDAQ: ELVN) Delayed: 48.60 +2.64 (5.74%)
Previous Close $45.96    52 Week High $ 
Open $45.01    52 Week Low $ 
Day High $48.79    P/E N/A 
Day Low $45.01    EPS $ 
Volume 1,981,815